Shanghai Bibo Biological Technology Co., Ltd – Trademark Portfolio

Entity Type: 16

Shanghai Bibo Biological Technology Co., Ltd holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 27 (Floor Coverings) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include LOVE DOU. The owner is based in Shanghai.

3Floor

NO.1 Yewang Road Yexie Town

Shanghai 201609 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

LOVE DOU
LOVE DOU
Registered 2019

Trademark Classifications

Shanghai Bibo Biological Technology Co., Ltd's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

27
Floor Coverings (1 filing)

Carpets, rugs, mats and matting, linoleum and other materials for covering floors

Frequently Asked Questions

How many trademarks does Shanghai Bibo Biological Technology Co., Ltd have?

Shanghai Bibo Biological Technology Co., Ltd has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Shanghai Bibo Biological Technology Co., Ltd file in?

Shanghai Bibo Biological Technology Co., Ltd files trademarks across 1 Nice Classification class. The most active classes are Class 27 (Floor Coverings). Class 27 covers carpets, rugs, mats and matting, linoleum and other materials for covering floors.

What are Shanghai Bibo Biological Technology Co., Ltd's most well-known trademarks?

Shanghai Bibo Biological Technology Co., Ltd's registered trademark portfolio includes well-known marks such as LOVE DOU. These are among 1 currently registered trademark in the portfolio.

What is Shanghai Bibo Biological Technology Co., Ltd's trademark registration success rate?

Shanghai Bibo Biological Technology Co., Ltd has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.